These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation. Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822 [TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. Eisenberg MJ; Filion KB; Yavin D; Bélisle P; Mottillo S; Joseph L; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Pilote L CMAJ; 2008 Jul; 179(2):135-44. PubMed ID: 18625984 [TBL] [Abstract][Full Text] [Related]
28. Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled. Wu L; Sun S; He Y; Zeng J Int J Environ Res Public Health; 2015 Aug; 12(9):10235-53. PubMed ID: 26308034 [TBL] [Abstract][Full Text] [Related]
29. Which drug to be used in smoking cessation? Tønnesen P Pol Arch Med Wewn; 2008 Jun; 118(6):373-6. PubMed ID: 18619194 [TBL] [Abstract][Full Text] [Related]
31. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials. Rosen LJ; Galili T; Kott J; Goodman M; Freedman LS Addiction; 2018 May; 113(5):805-816. PubMed ID: 29377409 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Hartmann-Boyce J; Stead LF; Cahill K; Lancaster T Addiction; 2014 Sep; 109(9):1414-25. PubMed ID: 24995905 [TBL] [Abstract][Full Text] [Related]
34. Interventions for preventing weight gain after smoking cessation. Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis. Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166 [TBL] [Abstract][Full Text] [Related]
36. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. Rose JE; Behm FM Am J Psychiatry; 2014 Nov; 171(11):1199-205. PubMed ID: 24934962 [TBL] [Abstract][Full Text] [Related]
37. Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review. Leeman RF; Huffman CJ; O'Malley SS Alcohol Alcohol; 2007; 42(3):196-206. PubMed ID: 17526629 [TBL] [Abstract][Full Text] [Related]
38. The effect of Varenicline and Bupropion on smoking cessation: A network meta-analysis of 20 randomized controlled trials. Guo K; Wang S; Shang X; E F; Hou L; Li J; Li Y; Yang K; Li X Addict Behav; 2022 Aug; 131():107329. PubMed ID: 35397262 [TBL] [Abstract][Full Text] [Related]
39. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion. Etter JF; Schneider NG Nicotine Tob Res; 2013 Jan; 15(1):59-68. PubMed ID: 22529220 [TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece. Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]